About Distributed Bio
Distributed Bio is a Healthcare company based in San Francisco (United States) founded in 2010 by Jacob Glanville, and was acquired by Charles River Laboratories in December 2020. Next-generation antibody libraries and vaccines are developed. The company has 26 employees. Its chief executive, as recorded, is Jacob Glanville. Distributed Bio offers products and services including Antibody Phage Display Services, SuperHuman and Cosmic scFV Libraries, Tungsten VHH Libraries, Tumbler Antibody Optimization Platform, and Retrogenix Off-Target Screening. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is DISTRIBUTED BIO, INC. Its competitors include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Distributed bio Inc has computational immunology platform, called Abgenesis for mining of antibodies, peptides, and TCRs, using this technology they have produced their own SuperHuman Library of Antibodies. Along with this, they have a discovery platform and an epitope focusing vaccine technology to elicit immune responses against specific surfaces, Additionally, they offer Bioengineering services, antibody informatics, including sequence and structural analysis, affinity maturation and humanization, NextGen repertoire sequencing, phage display panning library analysis, and repertoire biomarker analysis.
- Headquarters San Francisco, United States
- Employees 26
- Founders Jacob Glanville
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website distributedbio.com
- Social LinkedIn X Facebook
- Acquired by Charles River Laboratories (Dec 2020)
- Legal Name Distributed Bio, Inc
- Latest Funding Round$197.34K (USD), Grant
Aug 2019
- InvestorsCharles River Laboratories
& 1 more
- Employee Count26
- Acquired byCharles River Laboratories
(Dec 2020)
Products & Services of Distributed Bio
Distributed Bio offers a comprehensive portfolio of products and services, including Antibody Phage Display Services, SuperHuman and Cosmic scFV Libraries, Tungsten VHH Libraries, Tumbler Antibody Optimization Platform, and Retrogenix Off-Target Screening.
Services for therapeutic antibody discovery using phage libraries.
Libraries for antibody discovery and development processes.
Libraries focused on nanobody creation for therapeutics.
Platform for antibody humanization, affinity maturation, and stability.
Services for in vitro and in vivo pharmacology testing.
End-to-end solutions for antibody programs and applications.
Funding Insights of Distributed Bio
- Total Rounds 1
- Last Round Grant — $197,339
- First Round $197,339
(Aug 2019)
- Investors Count 1
All 1 funding rounds of Distributed Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2019 | $197,339 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Distributed Bio
Distributed Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Charles River Laboratories and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Provider of drug discovery and preclinical development services | 1947 | criver.com | Wilmington, United States |
Investor details for Distributed Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Distributed Bio
1 people are tracked at Distributed Bio (1 in leadership); the tracked headcount is 26.
| Name | Role | Group |
|---|---|---|
Jacob Glanville | Co-Founder & CEO | Leadership |
Complete people profiles for Distributed Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Distributed Bio
3 dated milestones of Distributed Bio across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Distributed Bio is founded.
- Funding First funding round of $197K.
- Exit Acquired by Charles River Laboratories.
Competitors of Distributed Bio
Distributed Bio has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform |
Detailed competitors of Distributed Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Distributed Bio (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Distributed Bio
Complete news archive for Distributed Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Distributed Bio
Distributed Bio was founded in 2010 and raised its 1st funding round 9 years after it was founded.
Distributed Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Jacob Glanville is the CEO of Distributed Bio, as recorded in our data. They have also founded this company.
Distributed Bio has 26 employees.
Distributed bio Inc has computational immunology platform, called Abgenesis for mining of antibodies, peptides, and TCRs, using this technology they have produced their own SuperHuman Library of Antibodies. Along with this, they have a discovery platform and an epitope focusing vaccine technology to elicit immune responses against specific surfaces, Additionally, they offer Bioengineering services, antibody informatics, including sequence and structural analysis, affinity maturation and humanization, NextGen repertoire sequencing, phage display panning library analysis, and repertoire biomarker analysis.
Distributed Bio's top competitors include Sutro Biopharma, Avidity Biosciences and Vividion Therapeutics.
Distributed Bio offers Antibody Phage Display Services, SuperHuman and Cosmic scFV Libraries, Tungsten VHH Libraries, Tumbler Antibody Optimization Platform, and 2 more products and services.
Distributed Bio has 2 investors. Key investors include Charles River Laboratories, and HHS.
Distributed Bio operates through Distributed Bio, Inc.
Yes. Distributed Bio was acquired by Charles River Laboratories in December 2020.